Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 Diabetes. Graham TE, Raghinaru D, Afreen S, Ahmann A, et al. Diabetes Care 2025;48:2154-2159.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Graham TE, Raghinaru D, Afreen S, Ahmann A, et al. Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 Diabetes. Diabetes Care 2025;48:2154-2159.
PMID: 41264828